Inside the cell reside many tiny assembly factories and warehouses that gather together all of the proteins and RNAs—which ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial ...

The ALS Network, in partnership with 12 ALS United member organizations, announces the selection of its 2025 Research Innovation Grantees—an accomplished group of scientists and clinicians whose work ...

Inflammasome Therapeutics ( a clinical-stage biotech company developing a new class of drugs, Kamuvudines, for ophthalmic and neurological conditions, announced the company has signed a contract with ...

In this Sportsing Short, Chris Johnson joins Gloria Govan and Erica Lynn OKeith to reveal how player development can skyrocket with the right focus and feedback. Johnson explains how subtle changes in ...

COLUMBUS, Ohio, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Gnome Sciences, a molecular pathology and translational research services company, announced a significant advance in the fight against ALS ...

Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly when distinguishing it from clinically similar neurodegenerative disorders.

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease that affects the neurons in the brain and spinal cord. In the United States alone there are ...

Much of what people understand about ALS progression comes from the stories they see and hear most often — and those stories can be misleading. Social media amplifies the voices of people who have ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...